Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Tomato who wrote (3095)	9/15/2005 5:11:40 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 12215

pars.... difficult indication, crash and burn. it was a bad stock to have included. kosn.... lead molecule fails to impress, tox issue with next program in line. leverage gutted, still own some. exel..... still think it's a sound investment and own some. ptn...... story hasn't changed with respect to leverage, but the MC4 talk looks like MC4 b.s. as time passes. leukolight (wrong name, but you'll get it) is going to reach $200M/year? Riiiiiiiiiiiigggggght. own a smidge, but only for the humiliation. rigl.... I was in it for HCV. Got in late, but did sell at the top. consider the nose project an interesting, logical bet. just wouldn't pick them for the current list. these lists, after all, are lists of huge leverage. or they should be. windows like that open and close, rapidly. I wouldn't read much into absence. I don't. Exception pars. :-(